Genkyotex (France)
Genkyotex SA and Genkyotex Suisse SA are now wholly owned subsidiaries of Calliditas Therapeutics AB. You will be automatically redirected to the Calliditas website, where you can find information about setanaxib and the NOX inhibitor platform.
Basic Information
- Category: business
- Website: http://www.genkyotex.com/
Evidence and Sources
- Genkyotex (France) — Official Website (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Genkyotex (France).
- Canonical profile: https://brandsource.ai/brands/genkyotex-france
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/genkyotex-france/json-ld
- Citation profile API: https://brandsource.ai/api/brands/genkyotex-france/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (74/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Genkyotex SA and Genkyotex Suisse SA are now wholly owned subsidiaries of Calliditas Therapeutics AB. You will be automatically redirected to the Calliditas website, where you can find information about setanaxib and the NOX inhibitor platform.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.